[1]
“Evaluation of cellular, acellular, and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the STABLECAMP trial”, ijtr, vol. 1, no. Suppl 2, Oct. 2025, doi: 10.63676/yt45kp42.